Accurate Delta Vanddispergerbart granulat Danmark - dansk - SEGES Landbrug & Fødevarer

accurate delta vanddispergerbart granulat

fmc agricultural solutions a/s (tidligere: cheminova a/s) - diflufenican, metsulfuron-methyl, metsulfuron - vanddispergerbart granulat - 600 g/kg diflufenican ; 60 g/kg metsulfuron-methyl ; (~ 57,8 g/kg metsulfuron

Lodin 200 EC Flydende middel Danmark - dansk - SEGES Landbrug & Fødevarer

lodin 200 ec flydende middel

agrichem b. v. - fluroxypyr - flydende middel - 200 g/l fluroxypyr

Stomp Suspensionskoncentrat Danmark - dansk - SEGES Landbrug & Fødevarer

stomp suspensionskoncentrat

basf a/s - pendimethalin - suspensionskoncentrat - 400 g/l pendimethalin

Plenum 50 WG Vanddispergerbart granulat Danmark - dansk - SEGES Landbrug & Fødevarer

plenum 50 wg vanddispergerbart granulat

syngenta nordics a/s - pymetrozin - vanddispergerbart granulat - 500 g/kg pymetrozin

Armure Emulsionskoncentrat Danmark - dansk - SEGES Landbrug & Fødevarer

armure emulsionskoncentrat

syngenta nordics a/s - difenoconazol, propiconazol - emulsionskoncentrat - 150 g/l difenoconazol ; 150 g/l propiconazol

Azacitidine Celgene Den Europæiske Union - dansk - EMA (European Medicines Agency)

azacitidine celgene

celgene europe bv - azacitidin - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastiske midler - azacitidine celgene is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification,aml with >30% marrow blasts according to the who classification.

Quofenix Den Europæiske Union - dansk - EMA (European Medicines Agency)

quofenix

a. menarini industrie farmaceutiche riunite s.r.l. - delafloxacin meglumine - ef-erhvervede infektioner - antibakterielle midler til systemisk brug, - quofenix is indicated for the treatment of the following infections in adults:acute bacterial skin and skin structure infections (absssi),community-acquired pneumonia (cap), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4. 4 og 5. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..